Clinical Trials for Essential Thrombocythemia (ET)
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Essential Thrombocythemia (ET)
Essential thrombocythemia (ET), the overproduction of blood platelets within the bone marrow, can cause blood clotting, which may lead to heart attack or stroke.
Essential Thrombocythemia ET essential-thrombocytosis primary-thrombocytosis